ArticlePloS one2022

Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants.

Katherine E Zarn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.